Press Releases

 Filter by Provider

ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release first quarter 2025 results prior to the opening of the TASE market on Monday, May 19, 2025.

Watchmaker Genomics, a leader in high-performance genomics solutions, today announced an important milestone in providing comprehensive and robust automated solutions for next-generation sequencing (NGS) workflows. Its collaboration with Revvity has resulted in fully automated and verified methods for all of its DNA and RNA library preparation kits on the Sciclone™ G3 NGSx* liquid handling workstation – making Revvity the first provider to automate Watchmaker’s entire library preparation portfolio.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced multi-year, strategic collaborations with AstraZeneca (LSE/STO/Nasdaq: AZN) and Pathos AI, Inc., in which the companies will work together to build a multimodal foundation model in oncology which can be used to gather biological and clinical insights, discover novel drug targets, and develop therapeutics for the broader oncology community.

Alphastream, an AI-powered private credit intelligence platform, today announced its partnership with Intapp, a leading global provider of AI-powered solutions for professionals in advisory, capital markets and legal firms. Through this collaboration, Intapp will make Alphastream’s AI-driven platform available to its clients via an integration with Intapp DealCloud. Access to Alphastream’s platform within Intapp’s deal and relationship management platform will enable private credit investors to make faster, data-informed decisions across the entire credit lifecycle.

MIAMI, FLORIDA / ACCESS Newswire / April 23, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), or MIRA, a clinical-stage pharmaceutical company focused on developing novel therapeutics for neurologic and neuropsychiatric disorders, today announced the completion of in vitro release testing (IVRT) for its topical formulation of Ketamir-2. The formulation is under investigation for localized application in pain-related conditions.

Cognitive Credit, the leading provider of corporate credit data and analytics software, today announces the launch of self-service access to restricted access issuers via its web application. This new functionality enables Cognitive Credit clients to discover, access and manage restricted access issuer data and documentation - alongside data on public issuers - through a single web service.

Acushnet Holdings Corp. (NYSE: GOLF) (“Acushnet”) will publish its first quarter 2025 financial results on May 7, 2025 at approximately 6:45 a.m. Eastern Time. Acushnet will also issue an advisory news release announcing availability of the results via the Acushnet Investor Relations (http://www.acushnetholdingscorp.com/ir) and the U.S. Securities and Exchange Commission (https://www.sec.gov/cgi-bin/browse-edgar?company=acushnet&owner=exclude&action=getcompany) websites on May 7, 2025.

Exclaimer, the global leader in email signature management solutions, announces the launch of its LinkedIn Social Feeds feature. This integration lets businesses share LinkedIn posts directly in employee email signatures, uniting two key professional channels.

Banuba, a leading innovator in augmented reality (AR) technology, announces the launch of its new virtual try-on plugin for Shopify. This groundbreaking extension simplifies the integration of advanced AR features, empowering online store owners to enhance their customer experience and significantly boost sales performance.

Armis, the cyber exposure management & security company, today announced it is expanding its vulnerability exposure and assessment capabilities with the free availability of the Armis Vulnerability Intelligence Database. The community-driven database integrates exploited vulnerabilities, emerging threats and AI-powered insights, providing the cybersecurity industry with the knowledge organizations need to better prioritize and mitigate threats in real time.

H.U. Group Holdings, Inc. and its wholly-owned subsidiary Fujirebio Holdings, Inc. today announced that the Global Health Innovative Technology (GHIT) Fund has awarded a two-year, approximately $4.5 million grant to Fujirebio’s wholly-owned subsidiary, Fluxus, Inc. (Location: Sunnyvale, California), to develop an ultrasensitive point-of-care (POC) urine test for tuberculosis (TB). The test will utilize Fluxus’ novel single-molecule counting technology, with the potential to be used for both pulmonary and extrapulmonary TB in all patient populations.

Avon Lake, Ohio--(Newsfile Corp. - April 23, 2025) - Are you ready to get a grip? Design Engineering Inc., the...

SunOpta Inc. (“SunOpta” or the “Company”) (Nasdaq:STKL) (TSX:SOY), an innovative and sustainable manufacturer fueling the future of food, today announced that the Company will participate in the BMO Global Farm to Market Conference, to be held May 14-15, 2025 in New York, N.Y.

Keepit has teamed with Ingram Micro, a leading business-to-business platform company for the global technology ecosystem, to expand access to Keepit’s vendor-independent cloud solution for data backup and recovery for value-added resellers (VARs), managed service providers (MSPs), and managed security service partners (MSSPs) in the UK. The agreement will also help strengthen Keepit’s position in the UK market as a premium global provider of SaaS data protection solutions and services.

Nourish, the leading provider of nutrition counseling in the country, today announced a $70 million Series B funding round, bringing total funding to $115 million. The round was led by J.P. Morgan Private Capital’s Growth Equity Partners, with participation from Thrive Capital, Index Ventures, Y Combinator, Maverick Ventures, BoxGroup, Atomico, G Squared, and Pinegrove. The funding will accelerate product development, expand Nourish’s Registered Dietitian (RD) network, and deepen strategic partnerships across the healthcare ecosystem. Nourish will also continue to grow its team across all functions.

Epicrispr Biotechnologies, a biotechnology company focused on developing curative therapies, today announced a partnership with Springbok Analytics to incorporate advanced, AI-driven muscle MRI imaging and analysis into its first-in-human clinical trial of EPI-321, a potential first-in-class treatment for facioscapulohumeral muscular dystrophy (FSHD).

SailPoint, Inc. (NASDAQ: SAIL), a leader in unified identity security, today announced the launch of its first Software-as-a-Service (SaaS) instance in the Middle East, going live in May 2025.

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it will report its first quarter 2025 financial results on Wednesday, May 7, 2025, after the U.S. financial markets close.

Grenova, Inc., a Virginia-based innovator in sustainable laboratory technologies, today announced two significant milestones for the company: the appointment of Ted Hull to Grenova’s board, and the successful completion of a new round of growth equity capital. These developments support Grenova’s strategic vision to drive innovation, expand automation capabilities, and deliver transformative solutions to laboratories worldwide.

Company to spotlight ASSURE WCD performance and expanded clinical applications

WASHINGTON, April 23, 2025 (GLOBE NEWSWIRE) --

Global distribution agreements and a new Brazil office position Cloudbrink’s AI-powered platform to serve hybrid workforces in fast-growing emerging markets

With a track record of uniting global commercial teams, Schrumpf will focus on delivering measurable customer value, deepening strategic partnerships, and driving scalable growth.

DURHAM, N.C., April 23, 2025 (GLOBE NEWSWIRE) -- Codetta Bio, a leader in multi-omics innovation, today announced its presence at the American Association for Cancer Research (AACR) Annual Meeting 2025, where the company will officially launch the Concerto™ System, the first platform to enable simultaneous, quantitative measurement of proteins, DNA, and RNA from a single sample.

BOCA RATON, Fla., April 23, 2025 (GLOBE NEWSWIRE) -- Red Violet, Inc. (NASDAQ: RDVT), a leading analytics and information solutions provider, announced today that it will report its financial results for the first quarter ended March 31, 2025 after the close of the U.S. financial markets on Wednesday, May 7, 2025.

HONOLULU, April 23, 2025 (GLOBE NEWSWIRE) -- First Hawaiian, Inc. (NASDAQ:FHB), (“First Hawaiian” or the “Company”) today reported financial results for its quarter ended March 31, 2025.

Deepens Observability Capabilities with Error Monitoring and Session Replay

Beijing, April 23, 2025 (GLOBE NEWSWIRE) -- WiMi Developed a Quantum Computing-Based Feedforward Neural Network (QFNN) Algorithm

DALLAS, April 23, 2025 (GLOBE NEWSWIRE) -- Berry Corporation (bry) (NASDAQ: BRY) (“Berry” or the “Company”) today provided an update on its hedge and liquidity position, further bolstering the Company’s financial strength and visibility in the current commodity price environment. The Company raised the average hedged price in 2026 and 2027 by $6 per barrel on 2.3 MBbls/d. The Company’s oil volumes are 73% hedged for the remainder of 2025 and 63% hedged for 2026, based on the midpoint of Berry’s full year 2025 oil production guidance. Berry's latest hedge information is included in its current investor presentation available on the Company’s website at www.bry.com.

Entering Closed Beta, the New SpringServe Platform Reduces Layers Between Buyers and 99% of Streaming Supply

Survey Finds 60% of Big Multinationals Believe Their Data is not Prepared and Primed to Unlock GenAI’s Next-Generation Business Value; North America Leads Level of Trust in Data Over ROW

PARIS, April 23, 2025 (GLOBE NEWSWIRE) -- Main Capital Partners (‘Main’), Trace One, and STG Partners, LLC (‘STG’) are pleased to announce Main’s strategic acquisition of Trace One, a premier SaaS leader in Product Lifecycle Management (PLM) and compliance software, from its previous principal owner, STG. This landmark transaction marks Main Capital’s inaugural platform investment in France, following the recent opening of its Paris office in February 2025.

Initial Clinical Studies Completed with Significant Positive Results

SOUTH SAN FRANCISCO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced that the peer-reviewed journal NEJM Evidence published results from the Phase 2 BEHOLD study of UBX1325 in patients with diabetic macular edema (DME). As reported in the article titled, “Safety and Efficacy of Senolytic UBX1325 in Diabetic Macular Edema,” the results suggested that the selective clearance of senescent cells in the retina provided disease-modifying and long-lasting improvements in vision in patients with DME, supporting the potential of UBX1325 as a novel modality for retinal diseases.

Cloudbrink’s Applied Innovation Delivers the Industry’s Best SASE Application Performance

Ongoing Strategic Expansion of the Company’s Indie Horror Game Portfolio

MINNEAPOLIS and TORONTO, April 23, 2025 (GLOBE NEWSWIRE) -- Dayforce, Inc. (NYSE: DAY; TSX: DAY), a global leader in human capital management (HCM) technology that makes work life better, today announced the availability of its Dayforce™ platform in the Microsoft Azure Marketplace, an online store providing applications and services for use on Azure.

MARLBOROUGH, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced a collaboration with the Singapore Translational Cancer Consortium (STCC) on the STCC Unified PD1/PDL1 Evaluation of Response (SUPER) study.

SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced the succession of its Chief Executive Officer (“CEO”), Allan Camaisa, to Eric Poma, Ph.D., who was appointed as CEO and member of the Board of Directors of Calidi (“Board”), effective April 22, 2025. Mr. Camaisa will continue to serve as a member of the Board.

CleanCore Becomes Provider of Aqueous Ozone Cleaning Products Under GSA MAS Indefinite Delivery/Indefinite Quantity (IDIQ) Contract

Veriff’s customers can extend their trusted Web2 identity workflows into Web3 without disruption or added complexity.

RESTON, Va., April 23, 2025 (GLOBE NEWSWIRE) -- Comscore, Inc. (Nasdaq: SCOR), a trusted partner for planning, transacting and evaluating media, today announced that it plans to hold a conference call to discuss its financial results for the first quarter ended March 31, 2025 on Tuesday, May 6th at 5:00 p.m. ET.

Independent Data Monitoring Committee (the “DMC”) recommends continuation of sunRIZE trial as planned with no need to increase sample size

BOCA RATON, FL, April 23, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corporation (Nasdaq: JNVR) (the “Company”) today announced the appointment of Fei “John” Han as Chief Financial Officer, as well as Dan Kang (“DK”) as Head of Investor Relations. The new appointments underscore the Company’s commitment to building a world-class financial and investor relations function as it scales its crypto-forward treasury strategy.

SAN MATEO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that three poster presentations featuring additional analyses from the Phase 2b FASCINATE-2 study of denifanstat in MASH will be presented at the European Association for the Study of Liver (EASL) Congress 2025 being held May 7-10, 2025 in Amsterdam, Netherlands.

Brands and B2B sellers on Feedonomics can now capitalize on improved trust and conversion rates that come from selling on Amazon

DALLAS, April 23, 2025 (GLOBE NEWSWIRE) -- Westwood Holdings Group, Inc. (NYSE:WHG) will release its first quarter 2025 earnings after the close of the New York Stock Exchange on Wednesday, April 30, 2025. Following the release, the Company will host a live audio webcast and conference call at 4:30 pm Eastern Time (3:30 pm Central Time).

BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Wednesday, May 7, 2025 to report its first quarter 2025 financial results and provide a corporate update.

ANN ARBOR, Mich., April 23, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will report first quarter 2025 financial results before the market opens on Tuesday, May 6, 2025.

BRUSSELS, April 23, 2025 (GLOBE NEWSWIRE) -- Tenneco’s Clevite Elastomers business, a premier global partner to vehicle manufacturers in providing smoother, quieter, safer, and more sustainable ride experiences, will showcase its extensive portfolio of leading-edge NVH and thermal isolation solutions for EVs and other automotive applications during Auto Shanghai 2025, April 23-May 2 at the National Exhibition and Convention Center in Shanghai, China. Clevite Elastomers products and team members will be based in the Tenneco exhibit – Hall 2.2, Booth 2BG018 – throughout the show.